| Display title | Chemistry:Dipivefrine |
| Default sort key | Dipivefrine |
| Page length (in bytes) | 4,433 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 544470 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | Jworkorg (talk | contribs) |
| Date of page creation | 03:42, 9 March 2024 |
| Latest editor | Jworkorg (talk | contribs) |
| Date of latest edit | 03:42, 9 March 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Dipivefrine (INN) or dipivefrin (USAN), trade name Propine among others, is a prodrug of epinephrine, and is used to treat open-angle glaucoma. It is available as a 0.1% ophthalmic solution. It is no longer available in the United States. |
